Activating Your Body'sNatural Cancer Killers
If you or someone you love is facing cancer, join Dr. Sosa for a clear, no-pressure explanation of non-toxic, immune-based options — NK cell therapy, immunotherapy, and Cytotron — and how to understand whether they might fit your situation.
You're Registered!
Thank you, friend. Your seat is reserved — we'll send the Zoom link to your email before the event.
Need your link sooner? Get it via WhatsApp →
Join the Webinar on ZoomWhat You'll Discover
A clear, jargon-free walkthrough of the integrative science behind a non-toxic approach to cancer care — and what it could mean for you or someone you love.
How NK Cells Hunt Cancer
Why Natural Killer cells are a key part of your immune defense, and how they can be amplified, expanded, and reinfused to help recognize and target abnormal cells while aiming to limit harm to healthy tissue. (Investigational; not FDA-approved.)
Immunotherapy, Unlocked
How checkpoint inhibitors like OPDIVO® (nivolumab, FDA-approved) remove the "brakes" cancer places on your immune system — and how LAK and Dendritic Cell therapies, which remain investigational, are being explored alongside them.
The Cytotron Breakthrough
How RFQMR (Rotational Field Quantum Magnetic Resonance) technology — which holds an FDA Breakthrough Device designation (an investigational status, not FDA approval) — is being studied as a non-toxic approach in early clinical work.
Inside the 4-Week Program
What the Integrative Oncology Program in Mexico City actually involves — 12 consultations, 24+ lab assessments, and how to know if you may qualify.
The Webinar Agenda
A focused hour, ending with a live Q&A where Dr. Sosa takes your questions directly — including those submitted when you register.
Why the Immune System Holds the Key
The philosophy behind integrative oncology and what makes a non-toxic approach different.
NK Cells & Immunotherapy, Explained Simply
How NK, LAK, and Dendritic cell therapies — plus checkpoint inhibitors — turn your own defenses against cancer.
The Cytotron RFQMR Breakthrough
A look at this FDA Breakthrough Device–designated (investigational) technology and the tumor types being studied.
Inside the 4-Week Mexico City Program
The patient journey, candidacy, and what to expect — step by step.
Ask Dr. Sosa Anything
Open floor — bring your questions for a real, unscripted conversation.
Three Pillars of Integrative Immunotherapy
Each works with your body — not against it — and each amplifies the others.
NK Cell Immunotherapy
Among the immune system's first-line defenders, expanded ex vivo and reinfused to help recognize signals on stressed or abnormal cells, with the aim of limiting harm to healthy tissue. NK cell therapy for solid tumors is investigational and not FDA-approved.
Cytotron RFQMR
A non-invasive technology that, in early and largely uncontrolled studies, has been associated with tumor stabilization and improved quality of life in some patients. It is being studied as a non-toxic, investigational approach.
Integrative Oncology
A synergistic 4-week program combining immunotherapy, metabolic and microbiome support, nutrition, and emotional healing — personally overseen by Dr. Sosa.
See how it actually works
Three mechanisms, drawn simply. Tap each to explore what we'll walk through live — in plain language.
How NK cells spot trouble
Natural Killer cells weigh activating signals against inhibitory ones. Healthy cells show MHC class I "self" markers that hold NK cells back; stressed or cancerous cells often lose them — a trigger immunologists call "missing-self".
Illustrative simplification. NK cell therapy for solid tumors is investigational and not FDA-approved.
Releasing the immune "brakes"
Many tumors exploit the PD-1 / PD-L1 checkpoint: the tumor's PD-L1 presses the PD-1 "off-switch" on immune cells. Checkpoint inhibitors like OPDIVO® (nivolumab) bind PD-1 on the immune cell, blocking that signal — so the immune response can re-engage.
OPDIVO® (nivolumab) is FDA-approved for specific indications; combining it with cell therapies as part of an integrative protocol is investigational.
A non-toxic, investigational field
Cytotron applies finely-tuned, rotating magnetic-resonance bursts (RFQMR) to a target area. The aim being studied is to influence cell behavior without the toxicity of chemo or radiation.
Holds an FDA Breakthrough Device Designation (investigational status — not FDA approval). Published evidence is early-stage and largely uncontrolled.
A rapidly growing field of research
Immune-based and cell therapies are among the most active areas of cancer research worldwide. These figures describe the broader scientific fields the webinar explores — they are not a claim about any individual result.
Source: ClinicalTrials.gov (U.S. National Library of Medicine), retrieved June 2026. Figures reflect the overall research fields and do not represent outcomes of the Pathways to Heal program.
Dr. Carlos Armando Sosa LunaM.D. · Medical Director
One of Mexico's most distinguished physicians in cellular therapy and integrative oncology, Dr. Sosa combines military surgical training with over 25 years of clinical experience and more than 10,000 patients treated.
His evidence-informed approach integrates cutting-edge immunotherapy with comprehensive, whole-person care. Dr. Sosa personally reviews every potential patient case — and in this live session he'll answer your questions directly.
Save Your Free Seat
Seats for this live session are limited so Dr. Sosa can answer questions personally. Register below and we'll send your private Zoom link and a calendar invite.
- Live Q&A directly with Dr. Sosa
- Private Zoom link sent to your inbox
- Replay access if you can't attend live
- Free, no obligation — bring a loved one
4:00 PM Chicago (CDT) · 2:00 PM Los Angeles (PDT)
Duration: ~60 minutes · Hosted live on Zoom
"From the moment I arrived, I knew I was in the right place. The integrative approach gave me hope when I thought I had run out of options."
¿Prefiere español? Escríbanos por WhatsApp →
You're Registered!
Thank you, friend. Your seat is reserved. Check your email for the Zoom link — and add the webinar to your calendar so you don't miss it.
Join the Webinar on ZoomQuestions before the event? Message us on WhatsApp
Stories of Healing
"The doctor is very humane and stabilized me — and today I am doing well. I am grateful every day."
"The entire team treats you with warmth. I never felt like a number — I felt cared for, seen, and supported."
"From the moment I arrived, I knew I was in the right place. The integrative approach gave me hope."
(investigational — not FDA approval)
Webinar Questions
Yes — completely free and no obligation. It's an educational session to help you understand integrative immunotherapy options. You're welcome to invite a spouse, family member, or caregiver.
Register anyway. Everyone who signs up receives a replay link by email, so you can watch when it's convenient. Attending live is best, though — that's your chance to ask Dr. Sosa questions directly.
After registering you'll receive a private Zoom link by email, plus reminders before the event. Just click the link at 3:00 PM Mexico City time on Thursday, June 11 from any phone, tablet, or computer.
The webinar explains who the Integrative Oncology Program is designed for and how candidacy is evaluated. Dr. Sosa personally reviews each individual case — the session is the perfect first step to understand your options.
Yes — and we encourage it. There is an optional field in the registration form where you can type your question. Dr. Sosa and his team review submitted questions before the session and prioritize them during the live Q&A at the end. You're also welcome to ask questions live in the Zoom chat during the event.
No. The webinar is educational and informational only. It is not a substitute for personalized medical advice, diagnosis, or treatment from a qualified provider.
Your Story Isn't Over. It's a New Chapter.
Reserve your free seat to learn about investigational, immune-based approaches — and whether they may be worth discussing with your own care team. Guided by Dr. Sosa.
Free · No obligation · Can't attend live? Everyone who registers gets the replay.